Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022
May 06 2022 - 7:25AM
Biofrontera
Inc. (Nasdaq: BFRI),
a biopharmaceutical company specializing in the commercialization
of dermatological products, will report financial results for the
three months ended March 31, 2022 before the opening of the U.S.
financial markets on Friday, May 13, 2022 and will hold a
conference call that same day beginning at 11:00 a.m. Eastern time
to discuss those results, provide a business update and answer
questions.
Conference Call and Webcast
Information
Event: |
Biofrontera Inc. First Quarter 2022 Financial Results and Business
Update Conference Call |
Date: |
Friday, May 13, 2022 |
Time: |
11:00 a.m. Eastern time |
Conference call: |
1-877-877-1275 (U.S.)1-412-858-5202 (international) |
Webcast: |
Live and 90-day replay webcast are available here and at
www.investors.biofrontera-us.com. |
|
|
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based
biopharmaceutical company commercializing a portfolio of
pharmaceutical products for the treatment of dermatological
conditions with a focus on photodynamic therapy (PDT) and topical
antibiotics. The Company’s licensed products are used for the
treatment of actinic keratoses, which are pre-cancerous skin
lesions, as well as impetigo, a bacterial skin infection. For more
information, visit www.biofrontera-us.com.
Contacts
Biofrontera Inc.Anke zur
Mühlen+1 781 486 1539us-ir@biofrontera.com
LHA Investor RelationsTirth T.
Patel+1 212 201 6614tpatel@lhai.com
# # #
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Sep 2024 to Oct 2024
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Oct 2023 to Oct 2024